Results
|
1961.
|
|
|
1962.
|
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. [electronic resource] by
- Kottaridis, P D
- Gale, R E
- Frew, M E
- Harrison, G
- Langabeer, S E
- Belton, A A
- Walker, H
- Wheatley, K
- Bowen, D T
- Burnett, A K
- Goldstone, A H
- Linch, D C
Producer: 20011011
In:
Blood vol. 98
Availability: No items available.
|
|
1963.
|
|
|
1964.
|
|
|
1965.
|
|
|
1966.
|
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease. [electronic resource] by
- Fiedler, Walter
- Serve, Hubert
- Döhner, Hartmut
- Schwittay, Michael
- Ottmann, Oliver G
- O'Farrell, Anne-Marie
- Bello, Carlo L
- Allred, Randy
- Manning, William C
- Cherrington, Julie M
- Louie, Sharianne G
- Hong, Weiru
- Brega, Nicoletta M
- Massimini, Giorgio
- Scigalla, Paul
- Berdel, Wolfgang E
- Hossfeld, Dieter K
Producer: 20050421
In:
Blood vol. 105
Availability: No items available.
|
|
1967.
|
|
|
1968.
|
Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia. [electronic resource] by
- Bullinger, Lars
- Rücker, Frank G
- Kurz, Stephan
- Du, Juan
- Scholl, Claudia
- Sander, Sandrine
- Corbacioglu, Andrea
- Lottaz, Claudio
- Krauter, Jürgen
- Fröhling, Stefan
- Ganser, Arnold
- Schlenk, Richard F
- Döhner, Konstanze
- Pollack, Jonathan R
- Döhner, Hartmut
Producer: 20070920
In:
Blood vol. 110
Availability: No items available.
|
|
1969.
|
|
|
1970.
|
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia. [electronic resource] by
- Ravandi, Farhad
- Cortes, Jorge E
- Jones, Daniel
- Faderl, Stefan
- Garcia-Manero, Guillermo
- Konopleva, Marina Y
- O'Brien, Susan
- Estrov, Zeev
- Borthakur, Gautam
- Thomas, Deborah
- Pierce, Sherry R
- Brandt, Mark
- Byrd, Anna
- Bekele, B Nebiyou
- Pratz, Keith
- Luthra, Rajyalakshmi
- Levis, Mark
- Andreeff, Michael
- Kantarjian, Hagop M
Producer: 20100429
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
1971.
|
Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project. [electronic resource] by
- Loh, Mignon L
- Zhang, Jinghui
- Harvey, Richard C
- Roberts, Kathryn
- Payne-Turner, Debbie
- Kang, Huining
- Wu, Gang
- Chen, Xiang
- Becksfort, Jared
- Edmonson, Michael
- Buetow, Kenneth H
- Carroll, William L
- Chen, I-Ming
- Wood, Brent
- Borowitz, Michael J
- Devidas, Meenakshi
- Gerhard, Daniela S
- Bowman, Paul
- Larsen, Eric
- Winick, Naomi
- Raetz, Elizabeth
- Smith, Malcolm
- Downing, James R
- Willman, Cheryl L
- Mullighan, Charles G
- Hunger, Stephen P
Producer: 20130312
In:
Blood vol. 121
Availability: No items available.
|
|
1972.
|
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine. [electronic resource] by
- Bachas, Costa
- Schuurhuis, Gerrit Jan
- Hollink, Iris H I M
- Kwidama, Zinia J
- Goemans, Bianca F
- Zwaan, C Michel
- van den Heuvel-Eibrink, Marry M
- de Bont, Eveline S J M
- Reinhardt, Dirk
- Creutzig, Ursula
- de Haas, Valerie
- Assaraf, Yehuda G
- Kaspers, Gertjan J L
- Cloos, Jacqueline
Producer: 20101105
In:
Blood vol. 116
Availability: No items available.
|
|
1973.
|
|
|
1974.
|
|
|
1975.
|
|
|
1976.
|
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. [electronic resource] by
- Jain, Nitin
- Curran, Emily
- Iyengar, Neil M
- Diaz-Flores, Ernesto
- Kunnavakkam, Rangesh
- Popplewell, Leslie
- Kirschbaum, Mark H
- Karrison, Theodore
- Erba, Harry P
- Green, Margaret
- Poire, Xavier
- Koval, Greg
- Shannon, Kevin
- Reddy, Poluru L
- Joseph, Loren
- Atallah, Ehab L
- Dy, Philip
- Thomas, Sachdev P
- Smith, Scott E
- Doyle, L Austin
- Stadler, Walter M
- Larson, Richard A
- Stock, Wendy
- Odenike, Olatoyosi
Producer: 20140922
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20
Availability: No items available.
|
|
1977.
|
Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells. [electronic resource] by
- Weisberg, Ellen
- Liu, Qingsong
- Zhang, Xin
- Nelson, Erik
- Sattler, Martin
- Liu, Feiyang
- Nicolais, Maria
- Zhang, Jianming
- Mitsiades, Constantine
- Smith, Robert W
- Stone, Richard
- Galinsky, Ilene
- Nonami, Atsushi
- Griffin, James D
- Gray, Nathanael
Producer: 20130910
In:
PloS one vol. 8
Availability: No items available.
|
|
1978.
|
Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. [electronic resource] by
- Blau, Olga
- Baldus, Claudia Dorothea
- Hofmann, Wolf-Karsten
- Thiel, Gundula
- Nolte, Florian
- Burmeister, Thomas
- Türkmen, Seval
- Benlasfer, Ouidad
- Schümann, Elke
- Sindram, Annette
- Molkentin, Mara
- Mundlos, Stefan
- Keilholz, Ulrich
- Thiel, Eckhard
- Blau, Igor Wolfgang
Producer: 20120116
In:
Blood vol. 118
Availability: No items available.
|
|
1979.
|
Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing. [electronic resource] by
- Drissen, Roy
- Buza-Vidas, Natalija
- Woll, Petter
- Thongjuea, Supat
- Gambardella, Adriana
- Giustacchini, Alice
- Mancini, Elena
- Zriwil, Alya
- Lutteropp, Michael
- Grover, Amit
- Mead, Adam
- Sitnicka, Ewa
- Jacobsen, Sten Eirik W
- Nerlov, Claus
Producer: 20170601
In:
Nature immunology vol. 17
Availability: No items available.
|
|
1980.
|
|